{"id":89,"date":"2021-03-20T09:41:36","date_gmt":"2021-03-20T00:41:36","guid":{"rendered":"https:\/\/www.tauns.co.jp\/en\/?page_id=89"},"modified":"2024-11-28T13:41:27","modified_gmt":"2024-11-28T04:41:27","slug":"history","status":"publish","type":"page","link":"https:\/\/www.tauns.co.jp\/en\/profile\/history\/","title":{"rendered":"Corporate History"},"content":{"rendered":"\n
\n

1987<\/strong>
TAUNS Laboratories, Inc. was founded in Numazu (Shizuoka) to conduct research and development of in vitro diagnostics, research reagents, various analytical reagents and related systems.
Tokyo office was established and began operations. <\/p>\n\n\n\n

1994<\/strong>
A new head office building was constructed in Kozuwa (Numazu, Shizuoka).<\/p>\n\n\n\n

2001<\/strong>
A new diagnostic manufacturing factory (Numazu Factory) was constructed in Kozuwa (Numazu, Shizuoka).<\/p>\n\n\n\n

2002<\/strong>
The R&D department was spun off to form BL Co., Ltd.<\/p>\n\n\n\n

2007<\/strong>
Our platinum-gold colloid manufacturing process was patented.
A new head office building was constructed in Futaba-cho (Numazu, Shizuoka).
\"\"<\/p>\n\n\n\n

2008<\/strong>
TAUNS started production and sales of Capilia O157, a diagnostic test kit for E. coli O157 infection, and Capilia VT, a diagnostic test kit for enterohemorrhagic E. coli infection.
\nImunoAce Adeno, a rapid diagnostic test kit for adenovirus infection, was launched in Japan. It was the world\u2019s first rapid diagnostic test kit adopting the latest platinum-gold colloid nanotechnology.\n
\"\"<\/strong>
ImunoAce Flu, a rapid diagnostic test kit for influenza virus infection, was launched in Japan.
\"\"<\/strong><\/p>\n\n\n\n

2010<\/strong>
Line Judge FluA\/pdm, a research reagent, was launched in Japan. <\/p>\n\n\n\n

2011<\/strong>
Capilia MAC Ab ELISA, a diagnostic test kit for MAC pulmonary disease, was launched in Japan.<\/p>\n\n\n\n

2012<\/strong>
Kamishima Factory was established in Kamishima (Izunokuni, Shizuoka).
\"\"<\/strong>
Capilia TB-Neo, a diagnostic test kit for tuberculosis, was launched in Japan.
Head office was relocated to Kamishima (Izunokuni, Shizuoka).
ISO 13485 certification was acquired.
ImunoAce RSV Neo, a rapid diagnostic test kit for RS virus infection, was launched in Japan.<\/p>\n\n\n\n

2013<\/strong>
ImunoAce Strep A, a rapid diagnostic test kit for GABHS infection, was launched in Japan.<\/p>\n\n\n\n

2015<\/strong>
ImunoAce Mycoplasma, a rapid diagnostic test kit for mycoplasma infection, was launched in Japan.<\/p>\n\n\n\n

2016<\/strong>
ImunoAce hMPV, a rapid diagnostic test kit for human metapneumovirus infection, was launched in Japan.
TAUNS merged with BL Co., Ltd. and integrated its R&D department.<\/p>\n\n\n\n

2020<\/strong>
ImunoAce Flu\/RSV, a rapid diagnostic test kit for influenza virus and\/or RS virus infection, was launched in Japan.
Shimizu-cho Office\/R&D Center was established in Shimizu-cho (Sunto-gun, Shizuoka).
\"\"
ImunoAce Strep A Neo, a rapid diagnostic test kit for GABHS infection, was launched in Japan.
ImunoAce SARS-CoV-2, a rapid diagnostic test kit for SARS-CoV-2 infection, was launched in Japan.
\"\"
ImunoAce Noro, a rapid diagnostic test kit for norovirus infection, was launched in Japan.<\/p>\n\n\n\n

2021<\/strong>
ImunoAce SARS-CoV-2 \u2161, a rapid diagnostic test kit for SARS-CoV-2 infection, was launched in Japan.<\/p>\n\n\n\n

2022<\/strong>
ImunoAce SARS-CoV-2 Saliva, a rapid diagnostic test kit for SARS-CoV-2 infection, was launched in Japan.
ImunoAce SARS-CoV-2\/Flu, a rapid diagnostic test kit for SARS-CoV-2 and influenza virus infection, was launched in Japan.<\/p>\n\n\n\n

2023<\/strong>
TAUNS developed a zinc quantification kit “ACCUREAD Zn” and\na spectrophotometer “ACCUREAD” (distributed by Nobelpharma Co., Ltd.).<\/p>\n\n\n\n

2024<\/strong>
ImunoAce SARS-CoV-2 \u2162, a rapid diagnostic test kit for SARS-CoV-2 infection, was launched in Japan.
TAUNS listed its shares on the Standard Market of the Tokyo Stock\nExchange.<\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

1987TAUNS Laboratories, Inc. was founded in Numazu (Shizuoka) to conduct research and development of in vitro diagnostics, research reagents, various analytical reagents and related systems.Tokyo office was established and began operations. 1994A new head office building was constructed in Kozuwa (Numazu, Shizuoka). 2001A new diagnostic manufacturing factory (Numazu Factory) was constructed in Kozuwa (Numazu, Shizuoka). 2002The R&D department was spun off to form BL Co., Ltd. 2007Our platinum-gold colloid manufacturing process was patented.A new head office building was constructed in Futaba-cho (Numazu, Shizuoka). 2008TAUNS started production and sales of Capilia O157, a diagnostic test kit for E. coli O157 infection, and Capilia VT, a diagnostic test kit for enterohemorrhagic E. …<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":16,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-89","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t